Exploring the burden of short-term CHOP chemotherapy adverse events in post-transplant lymphoproliferative disease: a comprehensive literature review in lymphoma patients

Watson, C; Barlev, A; Worrall, J; Duff, S; Beckerman, R

Watson, C (corresponding author), Atara Biotherapeut Inc, Global Hlth Econ & Market Access Res, 611 Gateway Blvd,Ste 900, San Francisco, CA 94080 USA.

JOURNAL OF DRUG ASSESSMENT, 2021; 10 (1): 18

Abstract

Purpose: Cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) is a treatment for post-transplant lymphoproliferative disease (PTLD) following......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索